Atypical chemokine receptors in renal inflammation

Nephron - Experimental Nephrology

Volumn 115, Issue 4, 2010, Pages

  Segerer, Stephan ^a,b   Jedlicka, Jan ^a   Wüthrich, Rudolf P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Chemokine receptors; Chemokines; Duffy antigen receptor for chemokines; Interceptors; Nonsignaling receptor

Indexed keywords

ALPHA CHEMOKINE; CARRIER PROTEIN; CHEMOCENTRYX CHEMOKINE RECEPTOR; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; DUFFY ANTIGEN RECEPTOR FOR CHEMOKINE; G PROTEIN COUPLED RECEPTOR; INTERCEPTOR; PROTEIN D6; UNCLASSIFIED DRUG; BLOOD GROUP DUFFY SYSTEM; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CXCR; CHEMOKINE RECEPTOR D6; CMKOR1 PROTEIN, MOUSE; DARC PROTEIN, HUMAN; DFY PROTEIN, MOUSE;

HUMAN; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; ANIMAL; BLOOD GROUP DUFFY SYSTEM; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CHEMOKINES; DUFFY BLOOD-GROUP SYSTEM; HUMANS; KIDNEY; NEPHRITIS; RECEPTORS, CCR10; RECEPTORS, CELL SURFACE; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR;

EID: 77951231735     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313489     Document Type: Short Survey

References (74)

1. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998; 392: 565-568.
2. Sallusto F, Baggiolini M: Chemokines and leukocyte traffic. Nat Immunol 2008; 9: 949-952.
3. Thelen M, Stein JV: How chemokines invite leukocytes to dance. Nat Immunol 2008; 9: 953-959.
4. Middleton J, Patterson AM, Gardner L, Schmutz C, Ashton BA: Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood 2002; 100: 3853-3860.
5. Colditz IG, Schneider MA, Pruenster M, Rot A: Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance. Thromb Haemost 2007; 97: 688-693.
6. Segerer S, Djafarzadeh R, Grone HJ, Weingart C, Kerjaschki D, Weber C, Kungl AJ, Regele H, Proudfoot AE, Nelson PJ: Selective binding and presentation of CCL5 by discrete tissue microenvironments during re - nal inflammation. J Am Soc Nephrol 2007; 18: 1835-1844.
7. Ruster C, Wolf G: The role of chemokines and chemokine receptors in diabetic nephropathy. Front Biosci 2008; 13: 944-955.
8. Furuichi K, Wada T, Kaneko S, Murphy PM: Roles of chemokines in renal ischemia/reperfusion injury. Front Biosci 2008; 13: 4021-4028.
9. Wada T, Matsushima K, Kaneko S: The role of chemokines in glomerulonephritis. Front Biosci 2008; 13: 3966-3974.
10. Kulkarni O, Anders HJ: Chemokines in lupus nephritis. Front Biosci 2008; 13: 3312-3320.
11. Panzer U, Steinmetz OM, Stahl RA, Wolf G: Kidney diseases and chemokines. Curr Drug Targets 2006; 7: 65-80.
12. Rot A, von Andrian UH: Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004; 22: 891-928.
13. Comerford I, Litchfield W, Harata-Lee Y, Nibbs RJ, McColl SR: Regulation of chemotactic networks by 'atypical' receptors. Bioessays 2007; 29: 237-247.
14. Rot A: Contribution of Duffy antigen to chemokine function. Cytokine Growth Factor Rev 2005; 16: 687-694.
15. Haraldsen G, Rot A: Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines. Eur J Immunol 2006; 36: 1659-1661.
16. Hadley TJ, Peiper SC: From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. Blood 1997; 89: 3077-3091.
17. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J, Richmond A, Graham GJ, Segerer S, Nibbs RJ, Rot A: The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 2009; 10: 101-108.
18. Gardner L, Patterson AM, Ashton BA, Stone MA, Middleton J: The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. Biochem Biophys Res Commun 2004; 321: 306-312. (Pubitemid 39055746)
19. Horuk R, Wang ZX, Peiper SC, Hesselgesser J: Identification and characterization of a promiscuous chemokine-binding protein in a human erythroleukemic cell line. J Biol Chem 1994; 269: 17730-17733.
20. Cartron JP, Bailly P, Le Van Kim C, Cherif- Zahar B, Matassi G, Bertrand O, Colin Y: Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sang 1998; 74: 29-64.
21. Darbonne WC, Rice GC, Mohler MA, Apple T, Hebert CA, Valente AJ, Baker JB: Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-1369.
22. Segerer S, Cui Y, Eitner F, Goodpaster T, Hudkins KL, Mack M, Cartron JP, Colin Y, Schlöndorff D, Alpers CE: Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518-531.
23. Segerer S, Bohmig GA, Exner M, Colin Y, Cartron JP, Kerjaschki D, Schlöndorff D, Regele H: When renal allografts turn DARC. Transplantation 2003; 75: 1030-1034.
24. Segerer S, Regele H, Mac KM, Kain R, Cartron JP, Colin Y, Kerjaschki D, Schlöndorff D: The Duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000; 58: 1546-1556.
25. Girard JP, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzaeg P, Amalric F: Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol 1999; 155: 2043-2055.
26. Peiper SC, Wang ZX, Neote K, Martin AW, Showell HJ, Conklyn MJ, Ogborne K, Hadley TJ, Lu ZH, Hesselgesser J: The Duffy antigen/ receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor. J Exp Med 1995; 181: 1311-1317.
27. Hadley TJ, Lu ZH, Wasniowska K, Martin AW, Peiper SC, Hesselgesser J, Horuk R: Postcapillary venule endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the Duffy blood group antigen. J Clin Invest 1994; 94: 985-991.
28. Wick N, Haluza D, Gurnhofer E, Raab I, Kasimir MT, Prinz M, Steiner CW, Reinisch C, Howorka A, Giovanoli P, Buchsbaum S, Krieger S, Tschachler E, Petzelbauer P, Kerjaschki D: Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. Am J Pathol 2008; 173: 1202-1209.
29. Pruenster M, Rot A: Throwing light on DARC. Biochem Soc Trans 2006; 34: 1005-1008.
30. Zarbock A, Schmolke M, Bockhorn SG, Scharte M, Buschmann K, Ley K, Singbartl K: The Duffy antigen receptor for chemokines in acute renal failure: a facilitator of renal chemokine presentation. Crit Care Med 2007; 35: 2156-2163.
31. Vielhauer V, Allam R, Lindenmeyer MT, Cohen CD, Draganovici D, Mandelbaum J, Eltrich N, Nelson PJ, Anders HJ, Pruenster M, Rot A, Schlöndorff D, Segerer S: Efficient renal recruitment of macrophages and T cells in mice lacking the Duffy antigen/receptor for chemokines. Am J Pathol 2009; 175: 119-131.
32. Libert F, Passage E, Parmentier M, Simons MJ, Vassart G, Mattei MG: Chromosomal mapping of A1 and A2 adenosine receptors, VIP receptor, and a new subtype of serotonin receptor. Genomics 1991; 11: 225-227.
33. Libert F, Parmentier M, Lefort A, Dumont JE, Vassart G: Complete nucleotide sequence of a putative G protein coupled receptor: RDC1. Nucleic Acids Res 1990; 18: 1917. (Pubitemid 20139025)
34. Burns JM, Summers BC, Wang Y, Melikian A, Berahovich R, Miao Z, Penfold ME, Sunshine MJ, Littman DR, Kuo CJ, Wei K, Mc- Master BE, Wright K, Howard MC, Schall TJ: A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203: 2201-2213.
35. Balabanian K, Lagane B, Infantino S, Chow KY, Harriague J, Moepps B, Arenzana-Seisdedos F, Thelen M, Bachelerie F: The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005; 280: 35760-35766.
36. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635-638.
37. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998; 95: 9448-9453.
38. Ma Q, Jones D, Springer TA: The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999; 10: 463-471.
39. Dambly-Chaudiere C, Cubedo N, Ghysen A: Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev Biol 2007; 7: 23.
40. Perlin JR, Talbot WS: Signals on the move: chemokine receptors and organogenesis in zebrafish. Sci STKE 2007; 2007:pe45.
41. Boldajipour B, Mahabaleshwar H, Kardash E, Reichman-Fried M, Blaser H, Minina S, Wilson D, Xu Q, Raz E: Control of chemokine- guided cell migration by ligand sequestration. Cell 2008; 132: 463-473.
42. Knaut H, Schier AF: Clearing the path for germ cells. Cell 2008; 132: 337-339.
43. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ: CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007; 104: 15735-15740.
44. Gerrits H, van Ingen Schenau DS, Bakker NE, van Disseldorp AJ, Strik A, Hermens LS, Koenen TB, Krajnc-Franken MA, Gossen JA: Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. Genesis 2008; 46: 235-245.
45. Sierro F, Biben C, Martinez-Munoz L, Mellado M, Ransohoff RM, Li M, Woehl B, Leung H, Groom J, Batten M, Harvey RP, Martinez AC, Mackay CR, Mackay F: Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 2007; 104: 14759-14764.
46. Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S, Van Damme J: Proteolytic processing of CXCL11 by CD13/ aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 2007; 110: 37-44.
47. Mazzinghi B, Ronconi E, Lazzeri E, Sagrinati C, Ballerini L, Angelotti ML, Parente E, Mancina R, Netti GS, Becherucci F, Gacci M, Carini M, Gesualdo L, Rotondi M, Maggi E, Lasagni L, Serio M, Romagnani S, Romagnani P: Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 2008; 205: 479-490.
48. Van Rechem C, Rood BR, Touka M, Pinte S, Jenal M, Guerardel C, Ramsey K, Monte D, Begue A, Tschan MP, Stephan DA, Leprince D: Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1). J Biol Chem 2009; 284: 20927-20935.
49. Zabel BA, Wang Y, Lewen S, Berahovich RD, Penfold ME, Zhang P, Powers J, Summers BC, Miao Z, Zhao B, Jalili A, Janowska- Wieczorek A, Jaen JC, Schall TJ: Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009; 183: 3204-3211.
50. Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B: CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009; 113: 6085-6093.
51. Wang J, Shiozawa Y, Wang Y, Jung Y, Pienta KJ, Mehra R, Loberg R, Taichman RS: The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283: 4283-4294.
52. Bosco MC, Puppo M, Santangelo C, Anfosso L, Pfeffer U, Fardin P, Battaglia F, Varesio L: Hypoxia modifies the transcriptome of primary human monocytes: modulation of novel immune-related genes and identification of CC-chemokine ligand 20 as a new hypoxia-inducible gene. J Immunol 2006; 177: 1941-1955.
53. Infantino S, Moepps B, Thelen M: Expression and regulation of the orphan receptor RDC1 and its putative ligand in human dendritic and B cells. J Immunol 2006; 176: 2197-2207.
54. Poole LJ, Yu Y, Kim PS, Zheng QZ, Pevsner J, Hayward GS: Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma- associated herpesvirus. J Virol 2002; 76: 3395-3420.
55. Raggo C, Ruhl R, McAllister S, Koon H, Dezube BJ, Fruh K, Moses AV: Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res 2005; 65: 5084-5095.
56. Madden SL, Cook BP, Nacht M, Weber WD, Callahan MR, Jiang Y, Dufault MR, Zhang X, Zhang W, Walter-Yohrling J, Rouleau C, Akmaev VR, Wang CJ, Cao X, St Martin TB, Roberts BL, Teicher BA, Klinger KW, Stan RV, Lucey B, Carson-Walter EB, Laterra J, Walter KA: Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol 2004; 165: 601-608. (Pubitemid 38971389)
57. Floege J, Smeets B, Moeller MJ: The SDF-1/ CXCR4 axis is a novel driver of vascular development of the glomerulus. J Am Soc Nephrol 2009; 20: 1659-1661.
58. Takabatake Y, Sugiyama T, Kohara H, Matsusaka T, Kurihara H, Koni PA, Nagasawa Y, Hamano T, Matsui I, Kawada N, Imai E, Nagasawa T, Rakugi H, Isaka Y: The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. J Am Soc Nephrol 2009; 20: 1714-1723.
59. Gao C, Huan J: SDF-1 plays a key role in chronic allograft nephropathy in rats. Transplant Proc 2008; 40: 1674-1678.
60. Sakihama H, Masunaga T, Yamashita K, Hashimoto T, Inobe M, Todo S, Uede T: Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis. Circulation 2004; 110: 2924-2930.
61. Hoffmann U, Segerer S, Rümmele P, Krüger B, Pietrzyk M, Hofstädter F, Banas B, Krämer BK: Expression of the chemokine receptor CXCR3 in human renal allografts - a prospective study. Nephrol Dial Transplant 2006; 21: 1373-1381.
62. Fahmy NM, Yamani MH, Starling RC, Ratliff NB, Young JB, McCarthy PM, Feng J, Novick AC, Fairchild RL: Chemokine and chemokine receptor gene expression indicates acute rejection of human cardiac transplants. Transplantation 2003; 75: 72-78. (Pubitemid 36139698)
63. Hu H, Aizenstein BD, Puchalski A, Burmania JA, Hamawy MM, Knechtle SJ: Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant 2004; 4: 432-437.
64. Neusser MA, Kraus AK, Regele H, Cohen CD, Fehr T, Kerjaschk D, Wüthrich RP, Penfold MET, Schall T, Segerer S: The chemokine receptor CXCR7 is expressed on lymphatic endothelial cells in renal allograft rejection Kidney Int 2010 in press.
65. Nibbs R, Graham G, Rot A: Chemokines on the move: control by the chemokine 'interceptors' Duffy blood group antigen and D6. Semin Immunol 2003; 15: 287-294.
66. Nibbs RJ, Kriehuber E, Ponath PD, Parent D, Qin S, Campbell JD, Henderson A, Kerjaschki D, Maurer D, Graham GJ, Rot A: The betachemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001; 158: 867-877.
67. Graham GJ, McKimmie CS: Chemokine scavenging by D6: a movable feast? Trends Immunol 2006; 27: 381-386.
68. Weber M, Blair E, Simpson CV, O'Hara M, Blackburn PE, Rot A, Graham GJ, Nibbs RJ: The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 2004; 15: 2492-2508.
69. Martinez de la Torre Y, Locati M, Buracchi C, Dupor J, Cook DN, Bonecchi R, Nebuloni M, Rukavina D, Vago L, Vecchi A, Lira SA, Mantovani A: Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol 2005; 35: 1342-1346.
70. Gosling J, Dairaghi DJ, Wang Y, Hanley M, Talbot D, Miao Z, Schall TJ: Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J Immunol 2000; 164: 2851-2856.
71. Steinmetz OM, Panzer U, Kneissler U, Harendza S, Lipp M, Helmchen U, Stahl RA: BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int 2005; 67: 1616-1621.
72. Banas B, Wornle M, Berger T, Nelson PJ, Cohen CD, Kretzler M, Pfirstinger J, Mack M, Lipp M, Grone HJ, Schlöndorff D: Roles of SLC/CCL21 and CCR7 in human kidney for mesangial proliferation, migration, apoptosis, and tissue homeostasis. J Immunol 2002; 168: 4301-4307.
73. Comerford I, Milasta S, Morrow V, Milligan G, Nibbs R: The chemokine receptor CCXCKR mediates effective scavenging of CCL19 in vitro. Eur J Immunol 2006; 36: 1904-1916.
74. Kriegova E, Tsyrulnyk A, Arakelyan A, Mrazek F, Ordeltova M, Petzmann S, Zatloukal J, Kolek V, du Bois RM, Popper H, Petrek M: Expression of CCX CKR in pulmonary sarcoidosis. Inflamm Res 2006; 55: 441-445.